By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – EMD Millipore today announced that it has signed an agreement to acquire Seattle-based Amnis, a developer and manufacturer of high-speed cellular imaging instruments.

Amnis' technology is used for flow cytometry applications in academic, biotech, and pharmaceutical cell analysis and research. The acquisition complements EMD Millipore's existing Guava product offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.